© 2002 by European Society of Cardiology
Copyright © 2002, European Society of Cardiology
Structural and functional implications of the phospholamban hinge domain: impaired SR Ca2+ uptake as a primary cause of heart failure
aDepartment of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267-0575, USA
bDepartment of Molecular and Cellular Physiology, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
cCardiovascular Research, Orion Pharma, FIN-02101 Espoo, Finland
dVTT Biotechnology, FIN-00014 Helsinki, Finland
eDivision of Cardiology, Case Western Reserve University, Cleveland, OH 44106, USA
* Corresponding author. Tel.: +1-513-558-2327; fax: +1-513-558-2269. litsa.kranias{at}uc.edu
Objective: The role of sarcoplasmic reticulum (SR) in the onset and progression of heart failure is controversial. We tested the hypothesis that impairment of SR Ca2+ sequestration may be a primary cause for progressive left ventricular (LV) dysfunction and the phospholamban hinge domain may be critical in this process. Methods: A phospholamban hinge domain mutant (PLB/N27A) was introduced in the cardiac compartment of the phospholamban null mouse. An integrative approach was used to characterize the resulting cardiac phenotype at a structural, cellular, whole organ and intact animal level. Results: NMR analysis revealed a defined alteration in the
-helical configuration between residues Q22 to F35 in mutant phospholamban. Transgenic lines expressing similar levels of mutant compared to wild-type phospholamban exhibited super-inhibition of the SR Ca2+ ATPase affinity for Ca2+ (EC50 0.52 µM) in oxalate-supported Ca2+ uptake measurements, which translated into impaired relaxation and attenuated responses to β-adrenergic stimulation. Importantly, a blunted force–frequency relation was observed in mutant hearts preceding left ventricular dilation. Upon aging to 10 months, the predominantly diastolic dysfunction progressed to congestive heart failure, characterized by induction of a fetal gene program, cardiac remodeling, lung congestion, depressed systolic function and early mortality. Conclusion: Increased inhibition of Ca2+ sequestration may be a causative factor in the development of left ventricular dysfunction and myocyte remodeling leading to heart failure. Furthermore, the hinge domain may play an important role in transmitting PLBs regulatory effects on SERCA.
KEYWORDS Ca-pump; Calcium (cellular); Contractile function; Heart failure; SR (function)
1 Each author contributed equally to this manuscript.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Bupha-Intr, J. Laosiripisan, and J. Wattanapermpool Moderate intensity of regular exercise improves cardiac SR Ca2+ uptake activity in ovariectomized rats J Appl Physiol, October 1, 2009; 107(4): 1105 - 1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Guinto, T. E. Haim, C. C. Dowell-Martino, N. Sibinga, and J. C. Tardiff Temporal and mutation-specific alterations in Ca2+ homeostasis differentially determine the progression of cTnT-related cardiomyopathies in murine models Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H614 - H626. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Arvanitis, D. Sanoudou, F. Kolokathis, E. Vafiadaki, V. Papalouka, A. Kontrogianni-Konstantopoulos, G. N. Theodorakis, I. A. Paraskevaidis, S. Adamopoulos, G. W. Dorn II, et al. The Ser96Ala variant in histidine-rich calcium-binding protein is associated with life-threatening ventricular arrhythmias in idiopathic dilated cardiomyopathy Eur. Heart J., October 2, 2008; 29(20): 2514 - 2525. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhao, Q. Yuan, J. Qian, J. R. Waggoner, A. Pathak, G. Chu, B. Mitton, X. Sun, J. Jin, J. C. Braz, et al. The Presence of Lys27 Instead of Asn27 in Human Phospholamban Promotes Sarcoplasmic Reticulum Ca2+-ATPase Superinhibition and Cardiac Remodeling Circulation, February 21, 2006; 113(7): 995 - 1004. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Haghighi, F. Kolokathis, A. O. Gramolini, J. R. Waggoner, L. Pater, R. A. Lynch, G.-C. Fan, D. Tsiapras, R. R. Parekh, G. W. Dorn II, et al. A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy PNAS, January 31, 2006; 103(5): 1388 - 1393. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Alvarez, J. A. King, and M. I. Townsley Resistance to Store Depletion-induced Endothelial Injury in Rat Lung after Chronic Heart Failure Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1153 - 1160. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zamoon, F. Nitu, C. Karim, D. D. Thomas, and G. Veglia Mapping the interaction surface of a membrane protein: Unveiling the conformational switch of phospholamban in calcium pump regulation PNAS, March 29, 2005; 102(13): 4747 - 4752. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Asahi, K. Otsu, H. Nakayama, S. Hikoso, T. Takeda, A. O. Gramolini, M. G. Trivieri, G. Y. Oudit, T. Morita, Y. Kusakari, et al. Cardiac-specific overexpression of sarcolipin inhibits sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA2a) activity and impairs cardiac function in mice PNAS, June 22, 2004; 101(25): 9199 - 9204. [Abstract] [Full Text] [PDF] |
||||





